Named of Director RSUs Awarded on February 28, 2006Tamara A. Baum (Lead Director) 7,500 Joseph E. Breslin 5,000 Lawrence J. DuBow 5,000 Elliot F. Hahn, Ph.D. 5,000 Carter H. Eckert 5,000 Irwin C. Gerson 5,000 Melvin Sharoky, M.D. 5,000
Exhibit 10.108
Director Compensation
On February 28, 2006, Andrx Corporation granted Restricted Stock Units (RSUs) to Andrxs non-employee directors in the amounts listed below, with each unit representing the right to acquire one share of Andrx Group common stock. Subject to certain acceleration and other conditions set forth in each directors RSU agreement, the shares underlying these units vest in five equal annual installments beginning one year from the date of grant. Upon vesting, a portion of the vested shares may be withheld to satisfy applicable taxes.
Named of Director | RSUs Awarded on February 28, 2006 | |||
Tamara A. Baum (Lead Director) | 7,500 | |||
Joseph E. Breslin | 5,000 | |||
Lawrence J. DuBow | 5,000 | |||
Elliot F. Hahn, Ph.D. | 5,000 | |||
Carter H. Eckert | 5,000 | |||
Irwin C. Gerson | 5,000 | |||
Melvin Sharoky, M.D. | 5,000 |
Grant of RSUs to Named Executive Officers
On February 28, 2006, the Compensation Committee authorized a grant of RSUs to certain key employees based on Andrxs financial performance and the employees contribution to Andrx during 2005, with each unit representing the right to acquire one share of Andrx Group common stock. One RSU award vests in seven equal annual installments beginning one-year from the date of grant (the Long-Term Incentive Award). The other vests entirely on the fourth anniversary of the date of grant, but is subject to acceleration, in whole or in part, if Andrx meets certain future financial performance criteria (the Performance-Based Award). The RSUs are subject to certain acceleration and other condition set forth in the employees RSU Agreement. Upon vesting, a portion of the vested shares may be withheld to satisfy applicable taxes.
RSU grants on February 28, 2006 to Andrxs current Named Executive Officers are as follows:
Total RSUs Awarded | ||||||||||||
Long-Term Incentive | Performance-Based | on February 28, | ||||||||||
Named Executive Officer | Award | Award | 2006 | |||||||||
Thomas P. Rice, Andrx Corporation Chief Executive Officer | 40,000 | 10,000 | 50,000 | |||||||||
Angelo C. Malahias, Andrx Corporation President and Chief Financial Officer | 30,000 | 10,000 | 40,000 | |||||||||
Lawrence Rosenthal, Andrx Pharmaceuticals, Inc. President | 8,000 | 2,000 | 10,000 |